ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma

por Georgiou, Marina, Ntavelou, Panagiota, Stokes, William, Roy, Rajat, Maher, Geoffrey J., Stoilova, Tsvetana, Choo, Josephine A.M.Y., Rakhit, Callum P., Martins, Miguel, Ajuh, Paul, Horowitz, Neil, Berkowitz, Ross S., Elias, Kevin, Seckl, Michael J., Pardo, Olivier E.
Publicado 2022

Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma

por Georgiou, Marina, Ntavelou, Panagiota, Stokes, William, Roy, Rajat, Maher, Geoffrey J., Stoilova, Tsvetana, Choo, Josephine A.M.Y., Rakhit, Callum P., Martins, Miguel, Ajuh, Paul, Horowitz, Neil, Berkowitz, Ross S., Elias, Kevin, Seckl, Michael J., Pardo, Olivier E.
Publicado 2022

The structure-function relationship of oncogenic LMTK3

por Ditsiou, Angeliki, Cilibrasi, Chiara, Simigdala, Nikiana, Papakyriakou, Athanasios, Milton-Harris, Leanne, Vella, Viviana, Nettleship, Joanne E., Lo, Jae Ho, Soni, Shivani, Smbatyan, Goar, Ntavelou, Panagiota, Gagliano, Teresa, Iachini, Maria Chiara, Khurshid, Sahir, Simon, Thomas, Zhou, Lihong, Hassell-Hart, Storm, Carter, Philip, Pearl, Laurence H., Owen, Robin L., Owens, Raymond J., Roe, S. Mark, Chayen, Naomi E., Lenz, Heinz-Josef, Spencer, John, Prodromou, Chrisostomos, Klinakis, Apostolos, Stebbing, Justin, Giamas, Georgios
Publicado 2020